PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | |hepatocellular carcinoma |
| Sentences | 121 |
| PubMedID- 22743730 | Case report: a 60 year-old man underwent ldlt for hepatitis c virus-related cirrhosis with hepatocellular carcinoma. |
| PubMedID- 22966320 | Development of hepatocellular carcinoma in patients with chronic hepatitis c more than 10 years after sustained virological response to interferon therapy. |
| PubMedID- 26012225 | This study elucidated the role of insulin resistance assessed by the homeostasis model (homa-ir) in development of hepatocellular carcinoma associated with chronic hepatitis c infection. |
| PubMedID- 22439008 | stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection. |
| PubMedID- 23564522 | The effects of interferon (ifn) treatment and the post-ifn treatment alpha-fetoprotein (afp) levels on risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc) are unknown. |
| PubMedID- 21537363 | A 78-year-old male who experienced multiple recurrences of hepatocellular carcinoma (hcc) with hepatitis c virus (hcv)-related cirrhosis underwent transcatheter arterial chemoembolization and ablation and survived for more than 10 years. |
| PubMedID- 23125843 | The combined kir3ds1/hla-bw4-i80 genotype was also associated with decreased susceptibility for the development of hepatocellular carcinoma in patients with chronic hepatitis c virus (hcv; lopez-vazquez et al., 2005). |
| PubMedID- 26045707 | Conclusions: sustained virological response can reduce all-cause mortality and the incidence of hepatocellular carcinoma of patients with hepatitis c. |
| PubMedID- 22957141 | End-stage liver diseases as well as hepatocellular carcinoma attributable to chronic hepatitis c are increasingly serious problems2. |
| PubMedID- 26140089 | Aim: to evaluate the downstaging rates in hepatitis c virus-patients with hepatocellular carcinoma (hcc), treated with degradable starch microspheres transcatheter arterial chemoembolization (dsm-tace), to reach new-milan-criteria (nmc) for transplantation. |
| PubMedID- 23602201 | High tumor necrosis factor-alpha/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 24409059 | Latent hepatitis b is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 22695885 | Background: there is limited literature on hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of cirrhosis. |
| PubMedID- 23404391 | Repeat hepatectomies for hepatic malignant lymphoma and hepatocellular carcinoma associated with chronic hepatitis c: report of a case. |
| PubMedID- 22013259 | The first patient was a 45-year-old male hepatitis c related cirrhosis with hepatocellular carcinoma, child grade c, with refractory ascites, coagulopathy and mild hepatorenal syndrome. |
| PubMedID- 21619694 | Similar findings have been reported in previous studies, including hepatocellular carcinoma associated with chronic hepatitis c, gastric carcinoma, and sporadic endometrial carcinoma , suggesting an interaction of mdm2 snp309, infectious factor, and hormone factor. |
| PubMedID- 26469163 | Methods: thirty consecutive cases of percutaneous arterial chemoembolization for hepatocellular carcinoma with hepatitis c-related cirrhosis(male, 23; female, 7; age, 74+/-5.9; weight, 62.7+/-12.3 kg; child-pugh a, 23; child-pugh b, 7)were analyzed retrospectively. |
| PubMedID- 21286221 | A 72-year-old japanese man underwent partial resection of the liver for hepatocellular carcinoma associated with hepatitis c viral infection. |
| PubMedID- 22879825 | hepatocellular carcinoma complicates 5% of the chronic hepatitis c cases . |
| PubMedID- 23844083 | Protein kinase r modulates c-fos and c-jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis c virus infection. |
| PubMedID- 25469280 | Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis c virus infection: a prospective study. |
| PubMedID- 23395693 | Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis c: further evidence in decompensation cirrhosis. |
| PubMedID- 25544880 | Evaluation of hepatocellular carcinoma development in patients with chronic hepatitis c by eob-mri. |
| PubMedID- 24772876 | Concurrent development of non-hodgkin lymphoma and hepatocellular carcinoma in patient with chronic hepatitis c. |
| PubMedID- 24081938 | Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted. |
| PubMedID- 23860735 | Genetic variation near interleukin 28b and the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21319193 | Liver stiffness measurement (lsm) using fibroscan accurately assesses the degree of liver fibrosis and the risk of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 21234423 | A 73-year-old female with history of hepatocellular carcinoma due to long-standing hepatitis c, presented to the emergency center with a sudden syncopal episode at home. |
| PubMedID- 22419005 | Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
| PubMedID- 21157144 | A 57-yr-old female patient with hepatocellular carcinoma due to hepatitis c virus received a liver transplantation. |
| PubMedID- 26519622 | The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis c virus-related cirrhosis. |
| PubMedID- 24677195 | hepatocellular carcinoma screening in patients with compensated hepatitis c virus (hcv)-related cirrhosis aware of their hcv status improves survival: a modeling approach. |
| PubMedID- 22615799 | Similarly, hepatitis c infections are strongly associated with hepatocellular carcinomas, and schistosomiasis is a major cause of bladder cancer . |
| PubMedID- 22555181 | A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis c or b: a novel approach by using meta-regression. |
| PubMedID- 25559682 | The aim of the present study was to evaluate wfa(+) -m2bp as a predictor of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 22105231 | Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis c virus infection receiving interferon therapy: a single center study. |
| PubMedID- 26070204 | Serum wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis c after sustained virological response. |
| PubMedID- 24179611 | Chemoprevention of hepatocellular carcinoma in patients with hepatitis c virus related cirrhosis. |
| PubMedID- 23547582 | Screening for hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 22919246 | A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis c virus patients with hepatocellular carcinoma. |
| PubMedID- 23701091 | Objective: the objective of our study was to describe the cross-sectional imaging appearance of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection in the absence of advanced fibrosis and cirrhosis. |
| PubMedID- 21526141 | We report a case of hepatocellular carcinoma (hcc) with chronic hepatitis c virus infection successfully treated with percutaneous radiofrequency ablation (rfa) under live four-dimensional (4d) echo guidance. |
| PubMedID- 24463696 | Influence of human t-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 22414050 | Aim: the role of interferon (ifn) therapy on prevention of hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv)-related cirrhosis remains controversial. |
| PubMedID- 22899800 | A novel predictive score for hepatocellular carcinoma development in patients with chronic hepatitis c after sustained response to pegylated interferon and ribavirin combination therapy. |
| PubMedID- 24367218 | Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis c virus. |
| PubMedID- 22911171 | Methods: thirty-eight patients who underwent hepatectomy for hepatocellular carcinoma (hcc) with hepatitis c virus infection were included. |
| PubMedID- 20616578 | Impact of peginterferon maintenance therapy on the risk of developing hepatocellular carcinoma in patients with chronic hepatitis c virus. |
| PubMedID- 23099187 | Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis c: a prospective, multicenter study. |
| PubMedID- 20521755 | The american association for the study of liver diseases recommends ultrasound surveillance for hepatocellular carcinoma in persons with chronic hepatitis c virus infection and cirrhosis. |